The study being terminated involved patients with one copy of the F508del mutation and one copy of a mutation that results in minimal cystic fibrosis transmembrane conductance regulator
The Phase 2b AURA-LV study compared the efficacy of voclosporin added to current standard-of-care therapy mycophenolate mofetil against placebo plus CellCept in achieving complete remission (CR) in 265
The clinical trials will be undertaken across Edinburgh and South Ayrshire. NHS Lothian consultant ophthalmic surgeon Baljean Dhillon is one of 300 doctors across 24 different countries taking part
The heiGHt trial is similar to the company’s earlier phase 2 study in pediatric GHD that showed comparable safety, efficacy, and tolerability of once-weekly TransCon Growth Hormone to
Sustol is the first extended-release serotonin-3 (5-HT3) receptor antagonist approved to prevent acute and delayed nausea and vomiting associated with both moderately emetogenic chemotherapy and anthracycline and cyclophosphamide
The study will however continue as planned on the recommendation of an independent data monitoring committee (DMC). The MONARCH 2, Phase 3 trial is comparing a combination of
The new investment, which is part of preferred-stock financing, increased AstraZeneca’s stake in Moderna to 9%. The British drugmaker first invested in Moderna in 2013. The agreement signed
The US Food and Drug Administration approved the company’s investigational new drug application, while Health Canada has issued a no objection letter. Moberg Pharma will commence patient enrollment in
Ezutromid is an orally administered small molecule that is designed to modulate utrophin, a protein that is structurally and functionally similar to the dystrophin protein. The new formulation,
Selumetinib was assessed in combination with docetaxel chemotherapy as a second-line treatment in patients with KRAS mutation-positive (KRASm) locally-advanced or metastatic non-small cell lung cancer (NSCLC). The phase
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.